Angioplasty with nitinol stents shows promise as PAD treatment

Percutaneous transluminal angioplasty with nitinol stenting offers promise as a treatment for peripheral artery disease or critical limb ischemia, according to results of a new trial published in Catheterization and Cardiovascular Interventions, a Wiley journal published on behalf of the Society for Cardiovascular Angiography and Interventions. The XCELL trial proved that the procedure was safe on patients and successfully worked to boost wound healing, reduce pain and cut back on the need for amputation as a treatment option. The trial, which used Abbott's Xpert stent, involved stenting of the infrapopliteal arteries. And the 12-month wound healing rate with nitinol stenting generated results similar to the more invasive open heart surgery procedures. Release

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.